Patterns of intervention for renal lesions in von Hippel-Lindau disease

BJU International

Volumn 102, Issue 8, 2008, Pages 940-945

  Matin, Surena F ^a,b   Ahrar, Kamran ^b   Wood, Christopher G ^b   Daniels, Molly ^b   Jonasch, Eric ^b  

^a University of Texas MD Anderson Cancer Center ^*  (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Kidney cancer; Minimally invasive surgery; Radiofrequency ablation; RCC; Von Hippel Lindau

Indexed keywords

ADULT; ARTICLE; CANCER GROWTH; CANCER STAGING; CLINICAL ARTICLE; CLINICAL EVALUATION; CLINICAL FEATURE; COMPUTER ASSISTED TOMOGRAPHY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; KIDNEY CARCINOMA; KIDNEY INJURY; MALE; NEPHRECTOMY; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION; VON HIPPEL LINDAU DISEASE;

ADOLESCENT; ADULT; CARCINOMA, RENAL CELL; CHILD; CHILD, PRESCHOOL; EPIDEMIOLOGIC METHODS; HUMANS; KIDNEY NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NEPHRECTOMY; NEPHRONS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME; VON HIPPEL-LINDAU DISEASE;

EID: 52649143253     PISSN: 14644096     EISSN: 1464410X     Source Type: Journal    
DOI: 10.1111/j.1464-410X.2008.07718.x     Document Type: Article

References (32)

1. Maher ER, Iselius L, Yates JR et al. Von Hippel-Lindau disease: a genetic study. J Med Genet 1991 28 : 443 7
2. Neumann HP, Wiestler OD. Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus. Lancet 1991 337 : 1052 4
3. Hammel PR, Vilgrain V, Terris B et al. Pancreatic involvement in von Hippel-Lindau disease. The Groupe Francophone d'Etude de la Maladie de von Hippel-Lindau. Gastroenterology 2000 119 : 1087 95
4. Lonser RR, Glenn GM, Walther M et al. von Hippel-Lindau disease. Lancet 2003 361 : 2059 67
5. Neumann HP, Lips CJ, Hsia YE, Zbar B. Von Hippel-Lindau syndrome. Brain Pathol 1995 5 : 181 93
6. Richard S, David P, Marsot-Dupuch K, Giraud S, Beroud C, Resche F. Central nervous system hemangioblastomas, endolymphatic sac tumors, and von Hippel-Lindau disease. Neurosurg Rev 2000 23 : 1 22
7. Choyke PL, Glenn GM, Walther MM, Patronas NJ, Linehan WM, Zbar B. von Hippel-Lindau disease: genetic, clinical, and imaging features. Radiology 1995 194 : 629 42
8. Neumann HP, Bender BU. Genotype-phenotype correlations in von Hippel-Lindau disease. J Intern Med 1998 243 : 541 5
9. Niemela M, Lemeta S, Summanen P et al. Long-term prognosis of haemangioblastoma of the CNS: impact of von Hippel-Lindau disease. Acta Neurochirurgica 1999 141 : 1147 56
10. Gallou C, Chauveau D, Richard S et al. Genotype-phenotype correlation in von Hippel-Lindau families with renal lesions. Hum Mutat 2004 24 : 435 6
11. Walther MM, Choyke PL, Glenn G et al. Renal cancer in families with hereditary renal cancer: prospective analysis of a tumor size threshold for renal parenchymal sparing surgery. J Urol 1999 161 : 1475 9
12. Steinbach F, Novick AC, Zincke H et al. Treatment of renal cell carcinoma in von Hippel-Lindau disease: a multicenter study. J Urol 1995 153 : 1812 6
13. Herring JC, Enquist EG, Chernoff A, Linehan WM, Choyke PL, Walther MM. Parenchymal sparing surgery in patients with hereditary renal cell carcinoma: 10-year experience. J Urol 2001 165 : 777 81
14. Uzzo RG, Novick AC. Nephron sparing surgery for renal tumors: indications, techniques and outcomes. J Urol 2001 166 : 6 18
15. Hafez KS, Fergany AF, Novick AC. Nephron sparing surgery for localized renal cell carcinoma: impact of tumor size on patient survival, tumor recurrence and TNM staging. J Urol 1999 162 : 1930 3
16. Belldegrun A, Tsui KH, deKernion JB, Smith RB. Efficacy of nephron-sparing surgery for renal cell carcinoma: analysis based on the new 1997 tumor-node-metastasis staging system. J Clin Oncol 1999 17 : 2868 75
17. D'Armiento M, Damiano R, Feleppa B, Perdona S, Oriani G, De Sio M. Elective conservative surgery for renal carcinoma versus radical nephrectomy: a prospective study. Br J Urol 1997 79 : 15 9
18. Ploussard G, Droupy S, Ferlicot S et al. Local recurrence after nephron-sparing surgery in von Hippel-Lindau disease. Urology 2007 70 : 435 9
19. Pavlovich CP, Walther MM, Choyke PL et al. Percutaneous radio frequency ablation of small renal tumors: initial results. J Urol 2002 167 : 10 5
20. Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Renal cell carcinoma: clinical experience and technical success with radio-frequency ablation of 42 tumors. Radiology 2003 226 : 417 24
21. Park S, Anderson JK, Matsumoto ED, Lotan Y, Josephs S, Cadeddu JA. Radiofrequency ablation of renal tumors: intermediate-term results. J Endourol 2006 20 : 569 73
22. Gill IS, Remer EM, Hasan WA et al. Renal cryoablation: outcome at 3 years. J Urol 2005 173 : 1903 7
23. Pautler SE, Pavlovich CP, Mikityansky I et al. Retroperitoneoscopic- guided radiofrequency ablation of renal tumors. Can J Urol 2001 8 : 1330 3
24. Shingleton WB, Sewell PE Jr. Percutaneous renal cryoablation of renal tumors in patients with von Hippel-Lindau disease. J Urol 2002 167 : 1268 70
25. Shuin T, Yamasaki I, Ashida S, Tamura K. Health-related QOL in patients with von Hippel-Lindau disease is highly deteriorated after repetitive surgical treatments for VHL-related tumors in the CNS or visceral organ. 7th International Symposium on VHL and Hereditary Kidney Cancers London. Canada 2006
26. Ahrar K, Matin S, Wood CG et al. Percutaneous radiofrequency ablation of renal tumors: technique, complications, and outcomes. J Vasc Intervent Radiol 2005 16 : 679 88
27. Gervais DA, McGovern FJ, Arellano RS, McDougal WS, Mueller PR. Radiofrequency ablation of renal cell carcinoma: part 1, Indications, results, and role in patient management over a 6-year period and ablation of 100 tumors. AJR Am J Roentgenol 2005 185 : 64 71
28. Gervais DA, Arellano RS, Mueller P. Percutaneous ablation of kidney tumors in nonsurgical candidates. Oncology 2005 19 (Suppl. 4 6 11
29. Gill IS, Matin SF, Desai MM et al. Comparative analysis of laparoscopic versus open partial nephrectomy for renal tumors in 200 patients. J Urol 2003 170 : 64 8
30. McDougal WS, Gervais DA, McGovern FJ, Mueller PR. Long-term followup of patients with renal cell carcinoma treated with radio frequency ablation with curative intent. J Urol 2005 174 : 61 3
31. Stern JM, Svatek R, Park S et al. Intermediate comparison of partial nephrectomy and radiofrequency ablation for clinical T1a renal tumours. BJU Int 2007 100 : 287 90
32. National Institutes of Health. Evaluation study of Sunitinib Malate in patients with Von Hippel-Lindau Syndrome (VHL). Available at: http://www.clinicaltrials.gov/ct/show/NCT00330564. Accessed April 2007